Beating the big C
Prizes for outstanding cancer research go to Tübingen’s Professor Lars Zender and two oncologists from Ulm
Tübingen oncologist, Professor Lars Zender, receives the Württembergische Krebspreis project prize of €50,000 on October 13 for his research into primary liver cancer. Hepatocellular carcinoma (HCC) is the third most frequent form of fatal cancer worldwide, but the means of treating it are limited. Zender’s team uses RNA interference to find new vulnerabilities in the liver cancer cell genome. After identifying a new target structure, researchers can use RNA interference on the target gene and effectively test the effects on tumor growth. Zender’s team is using a comparable approach to identify new cancer genes in pancreatic and biliary tract cancers.
Two junior researchers also receive prizes for outstanding cancer research:
Dr. Patrick Schuler of the Ulm University Hospital receives €10,000 for his work on patients with head and neck tumors, whose immune systems are weakened both by the tumor and by chemotherapy, which makes it easier for the cancer to return. Schuler also investigates chronic infections of the mouth and throat which lead to cancer. The aim is to retard tumor growth via the various types of cells involved in the response to infection.
Medical student Stephanie Weissinger, University of Ulm, receives the junior researchers’ special prize of €2,500 for her work into the genetic profile of malignant cells in the various subgroups of melanoma. She aims to compile a list for clinical diagnostics.
The Prize will be awarded by the Chairman of the Dres. Carl Maximilian und Carl Manfred Bayer Foundation on Monday, 13 October 2014 at 2pm at Tübingen’s CRONA Klinikum (Hoppe-Seyler-Strasse 3). www.dres-bayer-stiftung.de
Prof. Dr. Claus D. Claussen, Vorsitzender Dres. Carl Maximilian und Carl Manfred Bayer-Stiftung
University of Tübingen
Phone: +49 7071 29-86794